ZAINAB SAVARD: Open Payments
NPI 1003565003 · CAMP LEJEUNE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,328 in 35 payments from 16 companies in 2025. Trend: 2023 $62 · 2024 $451 · 2025 $1,328
Food & beverage: $1,213Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $432 |
| ABBVIE INC. | 4 | $207 |
| Neurocrine BioSciences, Inc. | 3 | $152 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 4 | $47 |
| Alkermes, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $43 |
Products named: Auvelity, VRAYLAR, SPRAVATO, INGREZZA, REXULTI, COBENFY, ARISTADA, Qelbree.
Industry payments across NC — which companies pay providers there.
